Thrilled to simultaneously publish into @JOP_ASCO while presenting our work at #ASCOQLTY19 today! Thanks for collaboration from Cleveland Clinic IM and mentorship from David Harris towards our project examining initiatives to improve code status documentation. ascopubs.org/doi/abs/10.120…

Happy to share our #BacktoBedside ACGME funded project, a core part of my #IMProud experience ♥️ "Teaching residents how to Break Bad News (BBN): Piloting a resident-led curriculum and feedback ⓣⓐⓢⓚ ⓕⓞⓡⓒⓔ as a proof-of-concept study" BMJ STEL stel.bmj.com/cgi/content/fu…

Honored to join this collaboration and add to the discussion of utilizing biomarkers as a means of keeping immune checkpoint inhibitors in check. Stay tuned, as the leaders of this project have some phenomenal works in the pipeline. #JITC

Honored for the opportunity to collaborate w/ Journal for ImmunoTherapy of Cancer and this aspirational group of immuno-oncology thought leaders to address key topics for patients on ICI through the pandemic. Extra 🙌 to Turajlic Lab @ The Crick & her incredible efforts w/ the #CAPTUREstudy. jitc.bmj.com/content/9/7/e0…

Taking a long pause after hearing this news. An eternal legacy built through a life cut far too short. 🙏“The idea that some lives matter less is the root of all that is wrong with the world.”🙏

More than 30 teams of Roswell Park specialists were selected to present findings at #AACR22. The findings include research on new cancer drugs and new uses for beta-blockers. roswellpark.org/newsroom/20220…

Out today! Our editorial discussing spatial bio markers that are predictive of PD1 responses in melanoma! Cancer Research Moffitt Cancer Center aacrjournals.org/cancerres/arti…

About the smile: the standing ovation also meant that people saw what I knew: behind every one of these bars is a patient. I know every name and have seen almost everyone. I know their stories and their children. And I believe many are cured because of this. #ESMO22 #ChalabiPlot